Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00510094 · ClinicalTrials.gov registry record · Phase 3
Effectiveness of Treatment for Relational Aggression in Urban African American Girls
A Phase 3 study of Aggression, sponsored by Children's Hospital of Philadelphia.
- Completed
- Registry status
- Phase 3
- Development phase
- 144
- Enrollment target
- 1
- Study location
NCT00510094 is a Phase 3 study of Aggression that has completed, run by Children's Hospital of Philadelphia. The registered enrollment target is 144 participants, roughly in line with the 148-participant average among 21 other Aggression trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT00510094, a Phase 3 study of Aggression, has completed, sponsored by Children's Hospital of Philadelphia.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 144 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will evaluate the effectiveness of a school-based social cognitive group treatment in reducing aggression (bullying) among relationally aggressive urban African American girls.
Conditions Studied
Interventions
- BEHAVIORAL Friend to Friend program
- BEHAVIORAL Psychoeducational attention control intervention
Study Locations (1)
Pennsylvania
- The Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2007-10 |
| Est. Completion | 2015-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00510094
The ClinicalTrials.gov registry entry for NCT00510094 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 144 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 148-participant average among 21 other Aggression trials with a reported enrollment target. The listed sponsor is Children's Hospital of Philadelphia, which has 431 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Aggression appearing as the primary indexed condition, and to 2 interventions - of which Friend to Friend program is the first listed.
NCT00510094 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00510094 about?
NCT00510094 is a clinical study titled "Effectiveness of Treatment for Relational Aggression in Urban African American Girls". This study will evaluate the effectiveness of a school-based social cognitive group treatment in reducing aggression (bullying) among relationally aggressive urban African American girls.
What is the current status of trial NCT00510094?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 144 participants. The study started on 2007-10. Estimated completion is 2015-05.
What conditions does trial NCT00510094 study?
This clinical trial studies the following conditions: Aggression.
What interventions are being tested in trial NCT00510094?
The interventions under investigation include: Friend to Friend program (BEHAVIORAL), Psychoeducational attention control intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT00510094?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00510094 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aggression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Manage Emotions to Reduce Aggression (MERA)
RECRUITING · NA
-
Manualized Assessment and Treatment Model of Challenging Behavior
RECRUITING · NA
-
Refinements of Functional Communication Training
RECRUITING · NA
-
Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents and Adults With Autism
RECRUITING · Phase 2
-
Clinical Trial on Agitation in Alzheimer's Dementia
RECRUITING · Phase 2
-
Addressing Root Causes for Gun Violence Prevention (ARC-GVP)
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.